Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIB-C Melanoma”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)WithdrawnNCT03005639
What this trial is testing

ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma

Who this might be right for
Stage IIIB-C Melanoma
Inova Health Care Services
Testing effectiveness (Phase 2)WithdrawnNCT02812693
What this trial is testing

Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification

Who this might be right for
Stage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Joanne Jeter
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT03949153
What this trial is testing

Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis

Who this might be right for
Melanoma (Skin)
University Hospital, Strasbourg, France 19
Testing effectiveness (Phase 2)Study completedNCT01341158
What this trial is testing

NAM-Trial: Multiferon in Malignant Melanoma

Who this might be right for
Locoregional Metastases in Malignant Melanoma Stages IIIB/C
University Hospital Tuebingen 42
Early research (Phase 1)Study completedNCT01496807
What this trial is testing

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Study completedNCT04401995
What this trial is testing

Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab

Who this might be right for
Melanoma
Diwakar Davar 9
Early research (Phase 1)Ended earlyNCT01744171
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00470470
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT02036086
What this trial is testing

Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases

Who this might be right for
Melanoma
Sunnybrook Health Sciences Centre 24
Not applicableLooking for participantsNCT06754904
What this trial is testing

Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

Who this might be right for
Melanoma, Skin
D.J. (Dirk) Grünhagen 213
Testing effectiveness (Phase 2)Study completedNCT03618641
What this trial is testing

CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease

Who this might be right for
MelanomaLymph Node Cancer
Diwakar Davar 34
Testing effectiveness (Phase 2)Study completedNCT00070642
What this trial is testing

CPG 7909 Injection in Melanoma

Who this might be right for
Carcinoma, Melanoma
Pfizer 184
Testing effectiveness (Phase 2)UnknownNCT05097378
What this trial is testing

Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma

Who this might be right for
MelanomaCancer
CCTU- Cancer Theme 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Large-scale testing (Phase 3)Study completedNCT02388906
What this trial is testing

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 906
Large-scale testing (Phase 3)Study completedNCT03068455
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,844
Testing effectiveness (Phase 2)Ended earlyNCT04310397
What this trial is testing

Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma

Who this might be right for
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8
M.D. Anderson Cancer Center 4
Large-scale testing (Phase 3)Active Not RecruitingNCT02938299
What this trial is testing

Neoadjuvant L19IL2/L19TNF- Pivotal Study

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 214
Testing effectiveness (Phase 2)Active Not RecruitingNCT02231775
What this trial is testing

Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation

Who this might be right for
Stage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7
M.D. Anderson Cancer Center 58
Next Page